|
Operation time (min)
|
192 ± 13
|
241 ± 21
|
221 ± 7
|
< 0.001a
|
|
Intraoperativetransfusion
|
154 (26.9%)
|
68 (44.7%)
|
36 (31.8%)
|
< 0.001b
|
|
Postoperativehospital stay (days)
|
12.63 ± 1.45
|
15.25 ± 2.86
|
12.86 ± 1.68
|
< 0.001a
|
|
Examined lymph nodes
|
25.11 ± 13.71
|
28.38 ± 14.47
|
27.02 ± 11.32
|
0.018a
|
|
Non-lethal Complication
|
48 (8.4%)
|
34 (22.4%)
|
14 (12.4%)
|
< 0.001b
|
|
Anastomotic leakage
|
14
|
7
|
3
| |
|
Pancreas-related complications
|
6
|
10
|
0
| |
|
Lung pleura- related complications
|
7
|
6
|
2
| |
|
Wound complication
|
5
|
2
|
3
| |
|
Postoperative ileus
|
13
|
6
|
5
| |
|
Liver dysfunction
|
3
|
3
|
0
| |
|
Mortality*
|
3
|
9
|
1
|
NS
|
|
Postoperative chemotherapy
| | | |
0.118
|
|
Presence
|
406(69.4%)
|
96(16.4%)
|
83(14.2%)
| |
|
Absence
|
166(65.9%)
|
56(22.2%)
|
30(11.9%)
| |
